Merck’s stock rallies in opposition to a file after FDA OKs arterial-hypertension drug

      Admin
      Merck’s stock rallies in opposition to a file after FDA OKs arterial-hypertension drug

      Merck’s stock rallied into file territory Wednesday, after the drug huge’s remedy for pulmonary arterial hypertension, Winrevair, became as soon as licensed by the U.S. Food and Drug Administration…
      Read More

      Related Posts